These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21427495)

  • 1. Immunotherapy with Imiquimod increases the efficacy of Glucantime therapy of Leishmania major infection.
    Khalili G; Dobakhti F; Mahmoudzadeh-Niknam H; Khaze V; Partovi F
    Iran J Immunol; 2011 Mar; 8(1):45-51. PubMed ID: 21427495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy.
    Shamsi Meymandi S; Javadi A; Dabiri S; Shamsi Meymandi M; Nadji M
    Arch Iran Med; 2011 Jul; 14(4):238-43. PubMed ID: 21726098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial.
    Firooz A; Khamesipour A; Ghoorchi MH; Nassiri-Kashani M; Eskandari SE; Khatami A; Hooshmand B; Gorouhi F; Rashighi-Firoozabadi M; Dowlati Y
    Arch Dermatol; 2006 Dec; 142(12):1575-9. PubMed ID: 17178983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator.
    Arevalo I; Ward B; Miller R; Meng TC; Najar E; Alvarez E; Matlashewski G; Llanos-Cuentas A
    Clin Infect Dis; 2001 Dec; 33(11):1847-51. PubMed ID: 11692295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru.
    Miranda-Verástegui C; Llanos-Cuentas A; Arévalo I; Ward BJ; Matlashewski G
    Clin Infect Dis; 2005 May; 40(10):1395-403. PubMed ID: 15844060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
    Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
    J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis.
    Arevalo I; Tulliano G; Quispe A; Spaeth G; Matlashewski G; Llanos-Cuentas A; Pollack H
    Clin Infect Dis; 2007 Jun; 44(12):1549-54. PubMed ID: 17516397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice.
    Solgi G; Kariminia A; Abdi K; Darabi M; Ghareghozloo B
    Korean J Parasitol; 2006 Mar; 44(1):55-61. PubMed ID: 16514283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meglumine Antimoniate (Glucantime) Causes Oxidative Stress-Derived DNA Damage in BALB/c Mice Infected by Leishmania (Leishmania) infantum.
    Moreira VR; de Jesus LCL; Soares RP; Silva LDM; Pinto BAS; Melo MN; Paes AMA; Pereira SRF
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of combined therapy with silymarin and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice.
    Jabini R; Jaafari MR; Vahdati Hasani F; Ghazizadeh F; Khamesipour A; Karimi G
    Drug Res (Stuttg); 2015 Mar; 65(3):119-24. PubMed ID: 24623031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod.
    El-On J; Bazarsky E; Sneir R
    Exp Parasitol; 2007 Jun; 116(2):156-62. PubMed ID: 17306255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice.
    Nilforoushzadeh MA; Shirani-Bidabadi L; Zolfaghari-Baghbaderani A; Saberi S; Siadat AH; Mahmoudi M
    J Vector Borne Dis; 2008 Dec; 45(4):301-6. PubMed ID: 19248657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Garlic induces a shift in cytokine pattern in Leishmania major-infected BALB/c mice.
    Ghazanfari T; Hassan ZM; Ebtekar M; Ahmadiani A; Naderi G; Azar A
    Scand J Immunol; 2000 Nov; 52(5):491-5. PubMed ID: 11119248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of Glucantime therapy of murine Leishmania donovani infection by a synthetic immunopotentiating compound (CP-46,665-1).
    Adinolfi LE; Bonventre PF
    Am J Trop Med Hyg; 1985 Mar; 34(2):270-7. PubMed ID: 3985270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucantime efficacy in the treatment of zoonotic cutaneous leishmaniasis.
    Pourmohammadi B; Motazedian MH; Handjani F; Hatam GH; Habibi S; Sarkari B
    Southeast Asian J Trop Med Public Health; 2011 May; 42(3):502-8. PubMed ID: 21706927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action.
    Buates S; Matlashewski G
    J Infect Dis; 1999 Jun; 179(6):1485-94. PubMed ID: 10228071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis.
    Asilian A; Sadeghinia A; Faghihi G; Momeni A
    Int J Dermatol; 2004 Apr; 43(4):281-3. PubMed ID: 15090013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis.
    Adinolfi LE; Bonventre PF; Vander Pas M; Eppstein DA
    Infect Immun; 1985 May; 48(2):409-16. PubMed ID: 3988341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of natural naphthoquinones in BALB/c mice infected with Leishmania amazonensis and L. venezuelensis.
    Fournet A; Barrios AA; Muñoz V; Hocquemiller R; Cavé A
    Trop Med Parasitol; 1992 Dec; 43(4):219-22. PubMed ID: 1293723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental chemotherapy in cutaneous leishmaniasis. III. Effect of glucantime and humatin (P&D) on Leishmania garnhami and Leishmania braziliensis in hamsters].
    Rezzano S; Armas JA; Moreno G; Scorza JV
    Acta Cient Venez; 1984; 35(5-6):394-403. PubMed ID: 6537698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.